Strategic Acquisition Valeant Pharmaceuticals has a history of strategic acquisitions, including the acquisition of companies such as Bausch + Lomb and Sprout Pharmaceuticals. This indicates a potential interest in expanding product portfolios through acquisitions.
Technological Stack Valeant Pharmaceuticals utilizes a variety of technologies such as Google Analytics, DNN, jQuery UI, and Microsoft ASP.NET. Leveraging these technologies can offer opportunities for technology-oriented sales solutions or services targeting their tech stack.
Market Expansion With acquisitions like AcneFree, LLC and the launch of medications like flibanserin (Addyi), Valeant Pharmaceuticals shows a commitment to expanding its market presence. Identifying opportunities to support their market expansion efforts could be beneficial.
Financial Growth Potential Considering the revenue of over $1 billion, Valeant Pharmaceuticals demonstrates a strong financial standing. This financial health signifies potential for high-value partnerships or sales agreements that can capitalize on their financial stability.
Regulatory Compliance Solutions Recent scrutiny over issues like accounting practices and deceptive business activities highlight the need for regulatory compliance solutions. Companies offering services in compliance consulting or software solutions may find opportunities in assisting Valeant Pharmaceuticals in addressing these concerns.
Valeant Pharmaceuticals uses 5 technology products and services including Google Analytics, DNN, jQuery UI, and more. Explore Valeant Pharmaceuticals's tech stack below.
| Valeant Pharmaceuticals Email Formats | Percentage |
| First.Last@valeant.com | 96% |
| FLast@valeant.com | 3% |
| First.MiddleLast@valeant.com | 1% |
Pharmaceutical ManufacturingNew Jersey, United States10001+ Employees
The Valeant LInkedIn page has been discontinued. Please go to the Bausch Health (https://www.linkedin.com/company/bausch-health-companies) page for updates.
Company Overview
Funding & FinancialsValeant Pharmaceuticals's revenue is in the range of $1B
Funding & FinancialsValeant Pharmaceuticals's revenue is in the range of $1B
1-888-653-2347 
support@leadiq.com